ISSN: 0020-7136

International Journal of Cancer Q1 Unclaimed

Wiley-Liss Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

International Journal of Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 234. Journal with a Single blind Peer Review review system, and It has a price of 3650 €. The scope of the journal is focused on Cancer, Oncology, Cancer Epidemiology, Cancer Genetics, Tumor. It has an SJR impact factor of 2,475 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,475.

International Journal of Cancer focuses its scope in these topics and keywords: cancer, human, cell, prostate, breast, cells, patients, tumor, carcinoma, antigen, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Oncology (Q1)

Price

3650 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

2,475

SJR Impact factor

234

H Index

694

Total Docs (Last Year)

1726

Total Docs (3 years)

29130

Total Refs

10847

Total Cites (3 years)

1638

Citable Docs (3 years)

6,27

Cites/Doc (2 years)

41,97

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

JAMA oncology Q1
Annals of Oncology Q1
Molecular Cancer Q1
CA - A Cancer Journal for Clinicians Q1
Cancer Discovery Q1

Compare this journals

Aims and Scope

Best articles by citations

CD66b, CD66c and carcinoembryonic antigen (CEA) are independently regulated markers in sera of tumor patients

Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa

Assessment of health status and health-related quality of life in survivors of Hodgkin's disease in childhood

Serologic detection of diffuse large B-cell lymphoma-associated antigens

Cancer incidence among alcoholic liver disease patients in Finland: A retrospective registry study during years 1996-2013

Modification effects ofGSTM1,GSTT1 andCYP2E1 polymorphisms on associations between raw salted food and incomplete intestinal metaplasia in a high-risk area of stomach cancer

PCR with degenerate primers for highly conserved DNA polymerase gene of the herpesvirus family shows neither human herpesvirus 8 nor a related variant in bone marrow stromal cells from multiple myeloma patients

Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969-1989

Biologic properties of a Ch2 domain-deleted recombinant immunoglobulin

Improved immunogenicity of a self tumor antigen by covalent linkage to CD40 ligand

Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer

Reversal of breast cancer resistance protein (BCRP/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic

SHOW MORE ARTICLES

Analysis of T-cell-receptor ?-chain-gene usage in peripheral-blood and tumor-infiltrating lymphocytes from human non-small-cell lung carcinomas

Downregulation of metastasis suppressor genes in malignant pheochromocytoma

Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: An animal model for CEA-directed tumor immunotherapy

Deregulation of beta-catenin signal byHelicobacter pylori CagA requires the CagA-multimerization sequence

Small molecular modulators of JMJD1C preferentially inhibit growth of leukemia cells

SYUNZ-16, a newly synthesized alkannin derivative, induces tumor cells apoptosis and suppresses tumor growth through inhibition of PKB/AKT kinase activity and blockade of AKT/FOXO signal pathway

Reversal of drug resistance by erythromycin: Erythromycin increases the accumulation of actinomycin d and doxorubicin in multidrug-resistant cells

Viruses and Hodgkin disease: No evidence of novel herpesviruses in non-EBV-associated lesions

Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal antiinflammatory drugs

Betulinic acid, a natural cytotoxic agent, fails to trigger apoptosis in human Burkitt's lymphoma-derived B-cell lines

A survey of the human T-cell lymphotropic virus type I (HTLV-I) in South-Western Colombia

Endemic african kaposi's sarcoma is not associated with immunodeficiency